Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06845839
What this trial is testing

Study to Evaluate CAY001 in Healthy Volunteers

Who this might be right for
Healthy
Cayuga Biotech, Inc. 24
Early research (Phase 1)Study completedNCT06435676
What this trial is testing

Single and Multiple Doses HRS9531 Tablets in Healthy Subjects

Who this might be right for
Overweight or Obesity; Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT05095727
What this trial is testing

MRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)

Who this might be right for
Glycogen Storage Disease
ModernaTX, Inc. 15
Early research (Phase 1)Study completedNCT01884285
What this trial is testing

AZD8186 First Time In Patient Ascending Dose Study

Who this might be right for
Advanced Castrate-resistant Prostate Cancer CRPCSquamous Non-Small Cell Lung Cancer sqNSCLCTriple Negative Breast Cancer TNBC
AstraZeneca 147
Testing effectiveness (Phase 2)Study completedNCT02149420
What this trial is testing

PD of VAY736 in Patients With Primary Sjögren's Syndrome

Who this might be right for
Primary Sjögren's Syndrome
Novartis Pharmaceuticals 27
Early research (Phase 1)Study completedNCT03830125
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Bridge Biotherapeutics, Inc. 88
Early research (Phase 1)Study completedNCT03632291
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UB-221 as an Add-on Therapy in CSU Patients

Who this might be right for
Urticaria Chronic
United BioPharma 15
Early research (Phase 1)Study completedNCT01419990
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of GLPG0634 in Healthy Subjects

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 16
Testing effectiveness (Phase 2)Study completedNCT03257046
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease

Who this might be right for
Parkinson Disease
Intra-Cellular Therapies, Inc. 40
Early research (Phase 1)Study completedNCT03165227
What this trial is testing

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

Who this might be right for
Diabetic Nephropathies
Boehringer Ingelheim 75
Early research (Phase 1)Study completedNCT05302388
What this trial is testing

A Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic Hyperuricemia

Who this might be right for
Asymptomatic Hyperuricemia
Shanghai Institute Of Biological Products 45
Early research (Phase 1)Study completedNCT01285518
What this trial is testing

Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 84
Early research (Phase 1)Study completedNCT05079425
What this trial is testing

A First-in-Human Study to Assess Single and Multiple Doses of NXC736 in Healthy Participants

Who this might be right for
Healthy
NEXTGEN Bioscience 72
Testing effectiveness (Phase 2)Study completedNCT02185040
What this trial is testing

A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
Celgene 42
Early research (Phase 1)Study completedNCT04073589
What this trial is testing

Efgartigimod Co-administered Subcutaneously With rHuPH20 in Healthy Subjects

Who this might be right for
Healthy Volunteers
argenx 33
Early research (Phase 1)Study completedNCT01629849
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects

Who this might be right for
HealthyAsthma
Boehringer Ingelheim 84
Early research (Phase 1)Ended earlyNCT02134197
What this trial is testing

Dose-escalation Study of Lupartumab Amadotin (BAY1129980)

Who this might be right for
Neoplasms
Bayer 69
Testing effectiveness (Phase 2)Ended earlyNCT05019742
What this trial is testing

Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shanghai Pharma Biotherapeutics USA Inc. 3
Early research (Phase 1)Study completedNCT02771340
What this trial is testing

Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma

Who this might be right for
Uveal MelanomaChoroid Neoplasm
Iconic Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Ended earlyNCT05574010
What this trial is testing

Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)

Who this might be right for
Celiac Disease
Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA 128
Next Page